Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Carcinoma, Neuroendocrine × Somatostatin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 3 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoma, Neuroendocrine 1

Interventions

Cisplatin 4 Etoposide 3 Drug Therapy 2 Carboplatin 2 repotrectinib 1 lutetium Lu 177 dotatate 1 durvalumab 1 dostarlimab 1 belinostat 1 atezolizumab 1 Somatostatin 1 Paclitaxel 1 Nivolumab 1 Neoadjuvant Therapy 1 Magnetic Resonance Imaging 1 Ipilimumab 1 FOLFOXIRI protocol 1 EC regimen 1 DLL3 protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡